5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia

J. McCoy, F. A. Cadegiani, C. G. Wambier, S. Herrera, S. Vaño-Galván, N. A. Mesinkovska, P. M. Ramos, J. Shapiro, R. Sinclair, A. Tosti, A. Goren

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish
JournalJournal of the European Academy of Dermatology and Venereology
Issue number4
StatePublished - 1 Apr 2021

Cite this